Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM).

Pasello, Giulia; Marulli, Giuseppe; Polo, Valentina; Breda, Cristiano; Bonanno, Laura; Loreggian, Lucio; Rea, Federico; Favaretto, Adolfo

Pasello, Giulia; Marulli, Giuseppe; Polo, Valentina; Breda, Cristiano; Bonanno, Laura; Loreggian, Lucio; Rea, Federico; Favaretto, Adolfo.

Affiliation

Pasello G; Via Gattamelata 64, 35128, Padua, Italy. giulia.pasello@ioveneto.it

Anticancer Res ; 32(12): 5393-9, 2012 Dec.

Article in En | MEDLINE | ID: mdl-23225442

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Mesothelioma/drug therapy; Pleural Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Carboplatin/administration & dosage; Carboplatin/adverse effects; Cisplatin/administration & dosage; Cisplatin/adverse effects; Female; Glutamates/administration & dosage; Glutamates/adverse effects; Guanine/administration & dosage; Guanine/adverse effects; Guanine/analogs & derivatives; Humans; Male; Mesothelioma/radiotherapy; Mesothelioma/surgery; Middle Aged; Neoadjuvant Therapy; Pemetrexed; Pleural Neoplasms/radiotherapy; Pleural Neoplasms/surgery; Retrospective Studies

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Mesothelioma Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Anticancer Res Year: 2012 Document type: Article Affiliation country: Italy Country of publication: Greece

Search on Google

Add to My VHL

XML

PubMed Links